Mayne Pharma News and Activities
Presence
Headquarters: Australia
Mayne Pharma is a company listed under the stock ticker MYX (AU).
Acquisition, funding and merger involving Mayne Pharma.
- The project of Cosette Pharmaceuticals acquiring Mayne Pharma has been abandoned (posted on December 30 2025).
- Cosette Pharmaceuticals has announced the acquisition of Mayne Pharma (posted on February 25 2025).
Executives
View the org chart displaying its 12 main executives
Most searched biographies at Mayne Pharma
- Aaron Gray, Chief Executive Officer
- Bruce Robinson, Non-Executive Chairman of the Board
- Kathryn Macfarlane, Non-Executive Director
Popular executive movements at Mayne Pharma
- Shawn O'Brien, Director, Chief Executive Officer and Managing Director, has left the company (posted on February 23 2026).
- Aaron Gray, who was Chief Financial Officer, is promoted to Chief Executive Officer (posted on February 23 2026).
- Bruce Robinson, who was Director, is promoted to Non-Executive Chairman of the Board (posted on January 14 2026).
Click here to view some more movements at Mayne Pharma
Create your alert
to follow the executive moves at Mayne Pharma.
Pharmaceuticals
Mayne Pharma has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
- Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Mayne Pharma
Social media about Mayne Pharma
- Mayne Pharma on Wikipedia, Google News & Yahoo Finance
- Mayne Pharma on LinkedIn, X (Twitter) & YouTube
